Amgen K.K
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
See below for the Latest Amgen K.K News, Analysis, Profit Results, Share Price Information, and Commentary.
Amgen migraine advocacy project wins trophy at the Healthcare Asia Pharma Awards
Amgen migraine advocacy project wins trophy at the Healthcare Asia Pharma Awards
An online seminar gathered specialists, influencers, journalists, patients, and caregivers toend the stigma surrounding migraine.
Most Read
1. OUE Healthcare subsidiary secures majority stake in Rehab Matters 2. Sunway Medical Centre Ipoh to open in Q2 2025 3. Global senior living market to grow by $127.4b by 2028 4. Vietnam’s Tam Anh General Hospital Group unveils new facility in District 8 5. HK Hospital Authority appoints Governance and Structure Reform CommitteeResource Center
Read Here
Advertise
Sign Up
Awards
Apr
10
Events
Event News
The trade show, which was held in Singapore, successfully brought together over 13,000 visionary digital health innovators, government leaders, and industry pioneers from the medical and healthcare sectors.
